课题基金 / 基金详情

DEVELOPMENT OF NOVEL ALTERNATIVE METHODS FOR THE PREDICTION OF DRUG METABOLISM IN HUMANS

DEVELOPMENT OF NOVEL ALTERNATIVE METHODS FOR THE PREDICTION OF DRUG METABOLISM IN HUMANS
开发预测人体药物代谢的新替代方法
批准号:
06557124
负责人:
KAMATAKI Tetsuya
金额:
$5.31万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1996

项目摘要

项目成果

KAMATAKI Tetsuya的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have succeeded in establishing cell lines which stably expressed human NATI,NAT2, CYP1A2, CYP2E1, CYP3A4 and CYP3A7. We examined the cytotoxicity and mutagenicity of IQ and MeIQx in the cells expressing human CYP1A2, NAT1, and NAT2 alone or in combinations. The results led to the following conclusions : (a) no activation to produce cytotoxic and mutagenic metabolites from either compound was achieved by each enzyme alone ; (b) CYP1A2 in combination with NAT2 efficiently activated the compounds ; (c) expression of CYP1A2 togather with NAT1 was not effective for mutagemic activation. The cells expressing CYP2E1 showed 7-ethoxycoumarin OMICRON-deethylase activity. Moreover, these cells showed higher sensitivity to DMN in cytotoxicity assay as compared to parental cells. The cells expressing CYP3A4 and CYP3A7 were more sensitive to aflatoxin B_1 than parental cells. These cell lines provide a new valuable panel for studying the human metabolism of xenobiotics with an ability to directly … More relate to P450-catalyzed metabolism.(2) We established several lines of transgenic mice harboring a CYP3A7 transgene.Of all the six transgenic lines established, M2 mice expressed the CYP3A7 gene in many tissues such as in the kidney, small intestine, and skin, etc, while M10 mice expressed the CYP3A7 transgene in the liver and testis, at both mRNA and protein levels. The potential application of this transgenic mice in drug metabolism was assessed using midazolam (MZ) as a substrate. Administration of this drug through intraperitoneal injection into adult mice of line M10 resulted in significantly higher levels of both 1'-OH-MZ and 4-OH-MZ in mouse serum. Kinetic study using liver microsomes from adult M10 mice indicated a higher Vmax with the same Km values in 1'-hydroxylation of MZ as compared with nontransgenic mice. These results indicate that CYP3A7 expressed in these transgenic mice possesses normal catalytic activities towards MZ with characteristics similar to those in the human livers. Less
期刊论文(39)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y. Takahashi et al.: "Expression of aryl hydrocarbon receptor (AhR) and Ah receptor nuclear translocator (Arnt) in adult rabbits known to be non-responsive to cytochrome P450 1A1 (CYP1A1) inducers." Eur. J. Biochem.242. 512-518 (1996)
Y. Takahashi 等人:“已知对细胞色素 P450 1A1 (CYP1A1) 诱导剂无反应的成年兔子中芳基碳氢化合物受体 (AhR) 和 Ah 受体核转位子 (Arnt) 的表达。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hisashi Hashimoto et al.: "Fetus-specific CYP3A7 and adult-specific CYP3A4 expressed in Chinese hamster CHL cells have similar capacity to activate carcinogenic mycotoxins." Cancer Res.55. 787-791 (1995)
Hisashi Hashimoto 等人:“中国仓鼠 CHL 细胞中表达的胎儿特异性 CYP3A7 和成人特异性 CYP3A4 具有相似的激活致癌霉菌毒素的能力。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsutomu Sakuma et al.,: "Efficient complementary DNA directed expression of human fetal liver cytochrome P450(CYP3A7) in insect cells using baculovirus." Biochem. Mol. Biol. Intern.35. 447-455 (1995)
Tsutomu Sakuma 等人:“使用杆状病毒在昆虫细胞中高效互补 DNA 指导表达人胎肝细胞色素 P450 (CYP3A7)。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
35
    Basic Research for Individualized Medicine
    • 批准号:
      15209005
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $28.79万
    • 财政年份:
      2003
    • 负责人:
      KAMATAKI Tetsuya
    • 依托单位:
    In vivo model to predict human fetal toxicity of xenobiotics : Establishment and evaluation of humanized mice carrying multiple forms of human fetal drug metabolizing enzymes.
    • 批准号:
      13557214
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      KAMATAKI Tetsuya
    • 依托单位:
    Transcriptional regulation of the CYP3A7 gene specifically expressed in the human fetal liver.
    • 批准号:
      12470491
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.0万
    • 财政年份:
      2000
    • 负责人:
      KAMATAKI Tetsuya
    • 依托单位:
    Function of activation and deactivation enzymes for carcinogens-s and risk for cancer
    • 批准号:
      12213002
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $86.02万
    • 财政年份:
      2000
    • 负责人:
      KAMATAKI Tetsuya
    • 依托单位:
    国内基金
    海外基金
    底物杂泛性的P450氧化酶的理性改造及其在倍半萜C-H键活化中的应用
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      饶历
    • 依托单位:
    细菌特殊萜合成酶及P450酶的挖掘与功能研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    白腐真菌Pleurotus ostreatus细胞色素P450酶在药物活性化合物降解中的作用与机制研究
    • 批准号:
      2025JJ50102
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      卓睿
    • 依托单位:
    基于细胞色素P450/PPAR/ROS信号通路探究丹参酮IIA 抑制骨丢分子机理
    • 批准号:
      JCZRLH202500148
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位: